Showing 1 - 2 results of 2 for search 'Laura Hogenboom', query time: 0.03s Refine Results
  1. 1
    Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis

    Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis by Carla Rodriguez-Mogeda, Zoë Y. G. J. van Lierop, Susanne M. A. van der Pol, Loet Coenen, Laura Hogenboom, Alwin Kamermans, Ernesto Rodriguez, Jack van Horssen, Zoé L. E. van Kempen, Bernard M. J. Uitdehaag, Charlotte E. Teunissen, Maarten E. Witte, Joep Killestein, Helga E. de Vries

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination

    Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination by Koos P. J. van Dam, Laura Hogenboom, Eileen W. Stalman, Laura Y. L. Kummer, Maurice Steenhuis, Maurice Steenhuis, Jim B. D. Keijser, Anja ten Brinke, S. Marieke van Ham, S. Marieke van Ham, Taco W. Kuijpers, Theo Rispens, Luuk Wieske, Luuk Wieske, Filip Eftimov, Eva M. Strijbis, Joep Killestein, Zoé L. E. van Kempen

    Published 2022-11-01
    Get full text
    Article

Search Tools: